Medicare Advantage Prior Authorization Bill Sinks Insurer Stocks

RegulationPrice Action
โดย Yahoo Finance·US·Read original
Summary · why it matters

Bipartisan lawmakers introduced the Protecting Approved Care Act, legislation aimed at reforming prior authorization and payment rules in Medicare Advantage plans, sending several health insurer stocks lower in the morning session. The bill, which received key backing from the American Association of Orthopaedic Surgeons, would require Medicare Advantage health plans to honor initial prior authorizations and strictly prohibit retroactive payment clawbacks. If enacted, the legislation would curtail insurers' ability to adjust or deny reimbursements post-treatment, potentially increasing medical loss ratios and raising administrative compliance burdens across managed care organizations. Among the stocks impacted, Alignment Healthcare fell 12.6%, Clover Health fell 4.8%, Novavax fell 3.6%, and Astrana Health fell 2.7%. Alignment Healthcare's shares are very volatile and have had 23 moves greater than 5% over the last year, and the stock is down 49% since the beginning of the year, trading at $10.32 per share, 58% below its 52-week high of $24.56 from July 2026.

Impact on stocks 5

Aging Population▼ · 4 stocks
Alignment Healthcare LLC
ALHC
▼ NegativeRegulationrelevance

The Protecting Approved Care Act would bar retroactive clawbacks and force honoring of prior authorizations, raising medical loss ratios for Alignment Healthcare.

Astrana Health Inc
ASTH
▼ NegativeRegulationrelevance

Astrana Health fell as the Medicare Advantage prior-authorization reform bill threatens insurer reimbursement flexibility and raises compliance burdens.

Clover Health Investments Corp
CLOV
▼ NegativeRegulationrelevance

Clover Health dropped on the bill curtailing Medicare Advantage plans' ability to deny or claw back reimbursements post-treatment.

Biotech & Genomic Medicine▲ · 1 stocks
© 2026 MarketDXNews